MIT engineers create nanoparticles for delivering personalized cancer vaccines
October 30, 2026
The particles carry a customized dose of cancer antigens that can provoke a strong immune response against tumors.
The particles carry a customized dose of cancer antigens that can provoke a strong immune response against tumors.
Data supporting the expanded clearance came from the HALT study involving 130 patients.
A single dose of an antibody targeting immune cells helped some monkeys stay free of detectable virus long after stopping treatment.
MIT engineers designed a robotic enteroscope that can inch through the hard-to-reach small intestine, making biopsies and drug delivery easier.
By tracking over 1 million cells, researchers created a detailed map of embryonic development in mice. It could provide development and disease insights.
The clearance was secured 105 days after submission, with Deep Reasoning AI now planning to supply the platform in the US.
Pharaoh Neuro’s minimally invasive system for filtering cerebrospinal fluid has received a breakthrough designation from the FDA, with its design to clean out unwanted blood following certain internal brain bleeds
Abbott (NYSE: ABT) has secured an FDA approval for a minimally invasive system to plug new leaks in a replacement heart valve, without requiring the patient to undergo open surgery a second time.
Senseonics (NYSE: SENS) has launched its first clinical study of a transmitter-free version of its Eversense 365 continuous glucose monitor.
This targeted approach could offer a way to prevent the recurrence of aggressive brain tumors.